메뉴 건너뛰기
Ophthalmology
Volumn 113, Issue 11, 2006, Pages 2110.e1-2110.e3
Photodynamic Therapy for Focal RPE Leaks

(1)  Koh, Adrian H C a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

BENZOPORPHYRIN DERIVATIVE;
EID: 33750350390     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.06.008     Document Type: Letter
Times cited : (4)
References (6)
  • 1
    • 28344440277 scopus 로고    scopus 로고
    • Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy
    • Ober M.D., Yannuzzi L.A., Do D.V., et al. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 112 (2005) 2088-2094
    • (2005) Ophthalmology , vol.112 , pp. 2088-2094
    • Ober, M.D.1    Yannuzzi, L.A.2    Do, D.V.3
  • 2
    • 0342632445 scopus 로고    scopus 로고
    • Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report
    • Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group
    • Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 117 (1999) 1329-1345
    • (1999) Arch Ophthalmol , vol.117 , pp. 1329-1345
  • 3
    • 0346887106 scopus 로고    scopus 로고
    • Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level
    • Chan W.M., Lam D.S., Lai T.Y., et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87 (2003) 1453-1458
    • (2003) Br J Ophthalmol , vol.87 , pp. 1453-1458
    • Chan, W.M.1    Lam, D.S.2    Lai, T.Y.3
  • 4
    • 16844375997 scopus 로고    scopus 로고
    • Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial
    • Visudyne in Minimally Classic Choroidal Neovascularization Study Group
    • Visudyne in Minimally Classic Choroidal Neovascularization Study Group. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Arch Ophthalmol 123 (2005) 448-457
    • (2005) Arch Ophthalmol , vol.123 , pp. 448-457
  • 5
    • 12944314751 scopus 로고    scopus 로고
    • Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy
    • Xu T., Li Y., and Wu X. Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy. Lasers Med Sci 19 (2004) 150-154
    • (2004) Lasers Med Sci , vol.19 , pp. 150-154
    • Xu, T.1    Li, Y.2    Wu, X.3
  • 6
    • 0141430051 scopus 로고    scopus 로고
    • Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor
    • Schmidt-Erfurth U., Schlotzer-Schrehard U., Cursiefen C., et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44 (2003) 4473-4480
    • (2003) Invest Ophthalmol Vis Sci , vol.44 , pp. 4473-4480
    • Schmidt-Erfurth, U.1    Schlotzer-Schrehard, U.2    Cursiefen, C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.